Lumora welcomes expressions of interest for GMO test commercialisation after BART technology demonstrates ability to detect genetically modified contamination of crops rapidly and at very low levels on a portable instrument
30th April 2012
Lumora will present on Molecular Diagnostics for Resource Limited Settings at the One Nucleus event on Healthcare Technologies in September 2011.
12 September 2011
Lumora has been invited to give a talk entitled “Molecular for the masses: making molecular diagnostics accessible” as part of the UKTI supported Life Science Leadership Series run by One Nucleus
Lumora announces Joint Development and Licensing Agreement with 3M for its innovative BART technology.
31 August 2011
Lumora to present at two international conferences in September 2011
31 August 2011: London, UK: Lumora Ltd, Headquartered in Ely, Cambridgeshire, and 3M headquartered in St Paul, Minnesota, USA have signed a
Lumora Attracts Series B Funding.
26 May 2011
Lumora Ltd, the Molecular diagnostics company, developing next generation tests through its proprietary BART Technology platform, has secured £1.5 million from the completion of the company’s latest funding round, led by Catapult Venture Managers Ltd.
The capital injection will primarily be used to
BART technology published in respected scientific journal.
07 December 2010
Lumora is delighted to announce publication of a peer reviewed article in the Public Library of Science. The article describes Lumora's core BART technology detailing both the underlying biochemistry of the BART technology as well as its unique practical applications to molecular
Lumora recognised as one of the leading HealthTech companies in the UK.
07 December 2010
Lumora have been selected to represent the UK on a technology mission to San Francisco in January 2011 aligned with the JP Morgan Healthcare Conference where we will explore opportunities for growth with key investors, potential partners and customers, media and other
Lumora Secures TSB funding for Point-of-Care Clinical Sample Preparation.
11 August 2010
Lumora attracts funding of over £100,000 from the Technology Strategy Board (TSB) to support the company’s development of a rapid sample preparation solution for molecular diagnostics at the point of care. The funds will be used to develop a universal, single step,
Lumora is attending the AACC Conference on 25-28th July.
15 July 2010
Laurence Tisi (CEO) and Paul Weinberger (CMO) will be attending the annual AACC conference in Anaheim between the 25th and 28th of
Paul Weinberger joins Lumora.
17 May 2010
Lumora is pleased to announce today the appointment of Paul Weinberger as Chief Marketing Officer. Paul will be responsible for Corporate Marketing and Business Development, including licensing and commercial agreements. He brings extensive experience of molecular diagnostics business development from both
Lumora is attending the 40th MEDICA conference in Düsseldorf.
18 November 2009
Lumora will be attending the 40th annual meeting at MEDICA in Düsseldorf on the 18-20th November 2009.
Laurence Tisi PhD, CEO will be representing Lumora, where he will meet with potential partners interested in commercialising the molecular
Lumora makes the inaugural Killer Technology List.
22 September 2009
Lumora has been listed in the inaugural Business Weekly "Killer Technologies" league table of the 50 most disruptive technology businesses in the East of England.
Lumora speaking at the XIII International Symposium on Luminescence Spectroscopy.
02 September 2009
Lumora will be presenting two talks at the XIII International Symposium on Luminescence Spectroscopy, September 7-11, 2008 in Bologna, Italy:
- Simpler hardware using brighter assays: BART technology
(Sept. 10th, Session H2,
Lumora is attending the CoExtra International Conference in Paris.
03 June 2009
Lumora will be attending the CoExtra International Conference in Paris on 3-5 June 2009, and will be presenting talks and technology demonstrations:
- June 3rd, Session B2, 16:40: ‘Non-PCR based alternative analytical methods.’ (Guy Kiddle).
- June 4th: